Cargando…
Outcome effects of antiretroviral drug combinations in HIV-positive patients with chemotherapy for lymphoma: a retrospective analysis
Background The combination of combined active antiretroviral therapy (cART) with chemotherapy in the treatment of lymphoma in human immunodeficiency virus (HIV)-positive patients has improved the overall survival of these patients. However, drug–drug interactions between antineoplastic agents and th...
Autores principales: | Sombogaard, F., Franssen, E. J. F., Terpstra, W. E., Kerver, E. D., van den Berk, G. E. L., Crul, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208603/ https://www.ncbi.nlm.nih.gov/pubmed/29948741 http://dx.doi.org/10.1007/s11096-018-0620-1 |
Ejemplares similares
-
Risk of HIV-associated Hodgkin lymphoma during the first months after initiation of combination antiretroviral therapy
por: Lanoy, E, et al.
Publicado: (2010) -
Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies
por: Wang, Chaoyu, et al.
Publicado: (2022) -
Impact of Chemotherapy for HIV-1 Related Lymphoma on Residual Viremia and Cellular HIV-1 DNA in Patients on Suppressive Antiretroviral Therapy
por: Cillo, Anthony R., et al.
Publicado: (2014) -
Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
por: Destache, Christopher J, et al.
Publicado: (2009) -
CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi
por: Gopal, Satish, et al.
Publicado: (2016)